What Is 2-DG, The New Anti-Covid Drug Made By DRDO And Given Emergency Use Approval In India?

DCGI has granted approval for emergency use of a drug developed by Defence Research and Development Organisation (DRDO) to treat Covid-19. DRDO with the help of Hyderabad-based Dr Reddy's Laboratories has developed the anti-Covid therapeutic application of the drug 2-deoxy-D-glucose (2-DG). A higher proportion of patients treated with the drug tested negative for Covid in RT-PCR tests. #drugtotreatcovid19 #drdodevelopsdrugtotreatcovid #coviddruginindia #newanticoviddrug Follow CRUX on Instagram (@crux.india): https://bit.ly/3qSFx1K Follow CRUX on Facebook: https://bit.ly/2Lte7iF #GetCloserToTheNews with latest headlines on politics, sports and entertainment on news18.com https://bit.ly/2Y4QccL Also watch: Crux One Take: https://bit.ly/3oNaLWf Crux Files: https://bit.ly/3mnbnjW Crux BTS: https://bit.ly/3oCjbQE